David G. McLeod

17.8k total citations · 2 hit papers
271 papers, 13.3k citations indexed

About

David G. McLeod is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, David G. McLeod has authored 271 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Pulmonary and Respiratory Medicine, 54 papers in Surgery and 45 papers in Oncology. Recurrent topics in David G. McLeod's work include Prostate Cancer Treatment and Research (184 papers), Prostate Cancer Diagnosis and Treatment (130 papers) and Urologic and reproductive health conditions (34 papers). David G. McLeod is often cited by papers focused on Prostate Cancer Treatment and Research (184 papers), Prostate Cancer Diagnosis and Treatment (130 papers) and Urologic and reproductive health conditions (34 papers). David G. McLeod collaborates with scholars based in United States, United Kingdom and Denmark. David G. McLeod's co-authors include Judd W. Moul, Shiv Srivastava, Isabell A. Sesterhenn, Mario A. Eisenberger, Brent A. Blumenstein, Joseph T. Spaulding, E. David Crawford, F. Andrew Dorr, Phyllis J. Goodman and Ralph C. Benson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David G. McLeod

264 papers receiving 12.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

1989 1.2k citations David G. McLeod et al. profile →
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer

1998 685 citations David G. McLeod et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David G. McLeod	9.7k	3.0k	2.5k	2.4k	1.9k	271	13.3k
E. David Crawford	11.4k 1.2×	4.0k 1.3×	4.0k 1.6×	3.2k 1.3×	4.4k 2.3×	284	17.5k
Judd W. Moul	14.6k 1.5×	3.9k 1.3×	3.9k 1.6×	3.2k 1.3×	3.9k 2.0×	526	20.5k
Mitchell C. Benson	8.6k 0.9×	3.9k 1.3×	2.8k 1.1×	2.2k 0.9×	3.1k 1.6×	268	13.3k
Kurt Miller	9.1k 0.9×	4.6k 1.5×	2.9k 1.2×	3.5k 1.5×	2.1k 1.1×	358	14.7k
Alexandre de la Taille	10.8k 1.1×	5.2k 1.7×	1.9k 0.7×	2.6k 1.1×	3.7k 1.9×	471	15.7k
Jean B. deKernion	8.9k 0.9×	4.0k 1.3×	2.8k 1.1×	1.9k 0.8×	3.1k 1.6×	219	13.1k
Bertrand Tombal	10.9k 1.1×	1.8k 0.6×	3.2k 1.3×	2.6k 1.1×	1.5k 0.8×	459	14.2k
Brent A. Blumenstein	5.6k 0.6×	2.8k 0.9×	3.9k 1.6×	1.9k 0.8×	3.2k 1.7×	123	12.0k
David J. Grignon	14.6k 1.5×	6.0k 2.0×	3.5k 1.4×	3.7k 1.5×	4.9k 2.6×	364	20.8k
Steven Joniau	14.5k 1.5×	3.1k 1.0×	2.9k 1.1×	2.8k 1.1×	3.4k 1.8×	458	18.7k

Countries citing papers authored by David G. McLeod

Since Specialization

Citations

This map shows the geographic impact of David G. McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. McLeod more than expected).

Fields of papers citing papers by David G. McLeod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. McLeod. The network helps show where David G. McLeod may publish in the future.

Co-authorship network of co-authors of David G. McLeod

This figure shows the co-authorship network connecting the top 25 collaborators of David G. McLeod. A scholar is included among the top collaborators of David G. McLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. McLeod. David G. McLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenberg, Matt T., Albert Dobi, Amina Ali, et al.. (2024). Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American Men. Cancers. 16(4). 712–712. 2 indexed citations

McLeod, David G., et al.. (2023). High-throughput optical sensing of peri-cellular oxygen in cardiac cells: system characterization, calibration, and testing. Frontiers in Bioengineering and Biotechnology. 11. 1214493–1214493. 2 indexed citations

Wang, Sheng, Baichen Li, David G. McLeod, & Zhenyu Li. (2023). A handheld plug-and-play microfluidic liquid handling automation platform for immunoassays. HardwareX. 14. e00420–e00420. 3 indexed citations

Mohamed, Ahmed A., Charles P. Xavier, Gauthaman Sukumar, et al.. (2018). Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth. Cancer Research. 78(13). 3659–3671. 44 indexed citations

Mohamed, Ahmed A., Shyh‐Han Tan, Charles P. Xavier, et al.. (2017). Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells. Molecular Cancer Research. 15(10). 1308–1317. 33 indexed citations

Rastogi, Anshu, Shyh‐Han Tan, Shashwat Sharad, et al.. (2014). ERG Monoclonal Antibody in the Diagnosis and Biological Stratification of Prostate Cancer: Delineation of Minimal Epitope, Critical Residues for Binding, and Molecular Basis of Specificity. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 33(4). 201–208. 4 indexed citations

Petrovics, György, et al.. (2013). Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men. International Journal of Molecular Sciences. 14(8). 15510–15531. 62 indexed citations

Brassell, Stephen A., et al.. (2012). Health-related quality of life for men with prostate cancer—an evaluation of outcomes 12–24 months after treatment. Urologic Oncology Seminars and Original Investigations. 31(8). 1504–1510. 23 indexed citations

Cullen, Jennifer, Stephen A. Brassell, Yongmei Chen, et al.. (2011). Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort. SHILAP Revista de lepidopterología. 2011. 1–9. 26 indexed citations

10.

Whitman, Eric J., Mark M. Pomerantz, Yongmei Chen, et al.. (2010). Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy. Cancer Epidemiology Biomarkers & Prevention. 19(1). 1–8. 29 indexed citations

11.

Gates, Jeremy D., Mark G. Carmichael, Linda C. Benavides, et al.. (2009). Longterm Followup Assessment of a HER2/ neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients. Journal of the American College of Surgeons. 208(2). 193–201. 16 indexed citations

12.

Hu, Ying, Albert Dobi, Taduru Sreenath, et al.. (2008). Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer. Clinical Cancer Research. 14(15). 4719–4725. 75 indexed citations

13.

Sterbis, Joseph R., Chunling Gao, Bungo Furusato, et al.. (2008). Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival. Clinical Cancer Research. 14(3). 758–763. 18 indexed citations

14.

Harless, William G., et al.. (2007). An assessment of the virtual conversations method for prostate cancer patient education.. PubMed. 27(6). 499–506. 6 indexed citations

15.

Rosner, Inger L., Lakshmi Ravindranath, Bungo Furusato, et al.. (2007). Higher Tumor to Benign Ratio of the Androgen Receptor mRNA Expression Associates with Prostate Cancer Progression after Radical Prostatectomy. Urology. 70(6). 1225–1229. 25 indexed citations

16.

Liu, Aijun, Bungo Furusato, Lakshmi Ravindranath, et al.. (2007). Quantitative analysis of a panel of gene expression in prostate cancer—with emphasis on NPY expression analysis. Journal of Zhejiang University SCIENCE B. 8(12). 853–859. 15 indexed citations

17.

Paquette, Edmond L., et al.. (2002). Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing. Urology. 60(5). 756–759. 77 indexed citations

18.

Bauer, John J. & David G. McLeod. (1998). Hepatic Subcapsular Extension of Pelvic Lymphocele After Radical Retropubic Prostatectomy. Urology. 51(5). 846–848. 1 indexed citations

19.

Douglas, Thomas H., Ted O. Morgan, David G. McLeod, et al.. (1997). Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients. Cancer. 80(1). 107–114. 26 indexed citations

20.

Finger, Michael J. & David G. McLeod. (1995). Postoperative myocardial infarction after radical cystoprostatectomy masked by patient-controlled analgesia. Urology. 45(1). 155–157. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact